Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTs032220723
JPRN-jRCTs032220723
Completed
未知

Evaluation of clinical characteristics (solute removal characteristics) by different dilution methods of hemodiafilter MFX-W eco series

Okada Kazuyoshi0 sites8 target enrollmentMarch 24, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsChronic Kidney Disease

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Kidney Disease
Sponsor
Okada Kazuyoshi
Enrollment
8
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 24, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Okada Kazuyoshi

Eligibility Criteria

Inclusion Criteria

  • •Patients who meet all of the following criteria are eligible for this study.
  • •(1\)Patients who have undergone online HDF for more than 1 month at the time of informed consent
  • •(2\)Patients who can maintain a stable blood flow rate of 280 mL/min
  • •(3\)Patients using a hemodiafilter with a membrane area of 2\.5m2 or more
  • •(4\)Patients whose dialysis time is longer than 4 hours
  • •(5\)Patients who are ambulatory
  • •(6\)Patients who have given written informed consent to participate in this study
  • •(7\)Men and women aged 18 or over and under 85 at the time of obtaining consent

Exclusion Criteria

  • •In consideration of the safety of the study subjects, patients who meet any of the following critria will be excluded from this study.
  • •(1\) Patients who need to take other blood purification therapies such as peritoneal dialysis that may affect the evaluation of research equipment during the research period
  • •(2\) Patients who have a history of acute symptoms such as anaphylactic reactions caused by polyethersulfone membranes or polyvinylpyrrolidone (PVP) in the past
  • •(3\) Patients participating in other clinical studies that may affect the results of this study during the research period
  • •(4\)Those with renal failure due to serious illness.
  • •(5\) Other patients ineligible whom the principal investigator deems to conduct this study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Multicentric study on outcome of treatment of osteosarcoma in India, conducted by Indian Musculo Skeletal Oncology Society
CTRI/2023/05/053100Indian Musculo Skeletal Oncology Society (IMSOS)
Completed
Not Applicable
Prognostic prediction of head and neck squamous cell carcinomas with clinico-pathological parameters and Epidermal growth factor receptors expression status
CTRI/2018/05/014222MOHAMMAD AKHEE25
Recruiting
Not Applicable
Evaluation of clinical and functional parameters in patients with Hemophilia aged above 60 yearsD67HemophiliaD66Hereditary factor VIII deficiencyHereditary factor IX deficiency
DRKS00010176Goethe-Universität Frankfurt200
Not yet recruiting
Not Applicable
ELECTROLYTE STATE & OUTCOME IN SEVERE COVID-19 DISEASEHealth Condition 1: U071- COVID 19 virus identified
CTRI/2023/06/053513The Dean, GMCHA
Not yet recruiting
Not Applicable
Analysis of clinicopathologic characteristics, carcinogenic mechanisms and genetic abnormality in colorectal tumors with MSI including Lynch syndrome.ynch syndrome Colorectal tumor
JPRN-UMIN000025142Tokushima University Hospital, Department of Gastroenterology and Oncology20